L-Endoglin Overexpression Increases Renal Fibrosis after Unilateral Ureteral Obstruction

• Bárbara Oujo ,

  Contributed equally to this work with: Bárbara Oujo, José M. Muñoz-Félix

  Affiliations Renal and Cardiovascular Research Unit, Department of Physiology and Pharmacology, University of Salamanca, Salamanca, Spain, Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain, Institute Queen Sophie for Renal Research, Salamanca, Spain

  ⨯
• José M. Muñoz-Félix ,

  Contributed equally to this work with: Bárbara Oujo, José M. Muñoz-Félix

  Affiliations Renal and Cardiovascular Research Unit, Department of Physiology and Pharmacology, University of Salamanca, Salamanca, Spain, Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain, Institute Queen Sophie for Renal Research, Salamanca, Spain

  ⨯
• Miguel Arévalo,

  Affiliations Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain, Institute Queen Sophie for Renal Research, Salamanca, Spain, Department of Human Anatomy and Histology, University of Salamanca, Salamanca, Spain

  ⨯
• Elena Núñez-Gómez,

  Affiliations Renal and Cardiovascular Research Unit, Department of Physiology and Pharmacology, University of Salamanca, Salamanca, Spain, Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain, Institute Queen Sophie for Renal Research, Salamanca, Spain

  ⨯
• Lucía Pérez-Roque,

  Affiliations Renal and Cardiovascular Research Unit, Department of Physiology and Pharmacology, University of Salamanca, Salamanca, Spain, Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain, Institute Queen Sophie for Renal Research, Salamanca, Spain

  ⨯
• Miguel Pericacho,

  Affiliations Renal and Cardiovascular Research Unit, Department of Physiology and Pharmacology, University of Salamanca, Salamanca, Spain, Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain, Institute Queen Sophie for Renal Research, Salamanca, Spain

  ⨯
• María González-Núñez,

  Affiliations Renal and Cardiovascular Research Unit, Department of Physiology and Pharmacology, University of Salamanca, Salamanca, Spain, Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain, Institute Queen Sophie for Renal Research, Salamanca, Spain

  ⨯
• Carmen Langa,

  Affiliation Centro de Investigaciones Biológicas, Consejo Superior de Investigaciones Científicas, CSIC, and Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Spain

  ⨯
• Carlos Martínez-Salgado,

  Affiliations Renal and Cardiovascular Research Unit, Department of Physiology and Pharmacology, University of Salamanca, Salamanca, Spain, Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain, Institute Queen Sophie for Renal Research, Salamanca, Spain, Health Sciences Studies Institute of Castilla y León (IESCYL), Salamanca, Spain

  ⨯
• Fernando Perez-Barriocanal,

  Affiliations Renal and Cardiovascular Research Unit, Department of Physiology and Pharmacology, University of Salamanca, Salamanca, Spain, Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain, Institute Queen Sophie for Renal Research, Salamanca, Spain

  ⨯
• Carmelo Bernabeu,

  Affiliation Centro de Investigaciones Biológicas, Consejo Superior de Investigaciones Científicas, CSIC, and Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Spain

  ⨯
• José M. Lopez-Novoa

  * E-mail: jmlnovoa@usal.es

  Affiliations Renal and Cardiovascular Research Unit, Department of Physiology and Pharmacology, University of Salamanca, Salamanca, Spain, Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain, Institute Queen Sophie for Renal Research, Salamanca, Spain

  ⨯